BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19808711)

  • 1. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
    Jastaniah W; Aseeri M
    J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body surface area estimation in children using weight alone: application in paediatric oncology.
    Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
    Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
    Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
    Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface area in children: a simple formula.
    Furqan M; Haque A
    Indian Pediatr; 2009 Dec; 46(12):1085-7. PubMed ID: 19430073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
    Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
    Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two different formulas for body surface area in adults at extremes of height and weight.
    Fancher KM; Sacco AJ; Gwin RC; Gormley LK; Mitchell CB
    J Oncol Pharm Pract; 2016 Oct; 22(5):690-5. PubMed ID: 26385906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body surface area for adjustment of drug dose.
    Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scientific basis of body surface area-based dosing.
    Chatelut E; Puisset F
    Clin Pharmacol Ther; 2014 Apr; 95(4):359-61. PubMed ID: 24646485
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
    Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variance inflation in sequential calculations of body surface area, plasma volume, and prostate-specific antigen mass.
    Sivanandam A; Siva S; Bhandari M; Menon M
    BJU Int; 2008 Dec; 102(11):1573-80. PubMed ID: 18691174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body surface area in normal-weight, overweight, and obese adults. A comparison study.
    Verbraecken J; Van de Heyning P; De Backer W; Van Gaal L
    Metabolism; 2006 Apr; 55(4):515-24. PubMed ID: 16546483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of body surface area in various childhood ages--validation of the Mosteller formula.
    El Edelbi R; Lindemalm S; Eksborg S
    Acta Paediatr; 2012 May; 101(5):540-4. PubMed ID: 22211780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional dosing of anticancer agents: precisely wrong or just inaccurate?
    Bins S; Ratain MJ; Mathijssen RH
    Clin Pharmacol Ther; 2014 Apr; 95(4):361-4. PubMed ID: 24646486
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of fixed dosing of new anticancer agents in phase I studies.
    Levêque D
    Anticancer Res; 2008; 28(5B):3075-7. PubMed ID: 19031959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimens.
    Loos WJ; Gelderblom H; Sparreboom A; Verweij J; de Jonge MJ
    Clin Cancer Res; 2000 Jul; 6(7):2685-9. PubMed ID: 10914710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body surface area as a determinant of pharmacokinetics and drug dosing.
    Sawyer M; Ratain MJ
    Invest New Drugs; 2001 May; 19(2):171-7. PubMed ID: 11392451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.
    Portugal RD
    Med Hypotheses; 2005; 65(4):748-51. PubMed ID: 15979816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J; Toste B; Dizon DS
    Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.